Leafwell

Leafwell is a leading health-tech and telehealth platform dedicated to integrating medical cannabis into mainstream healthcare. Founded in 2019 by breast cancer survivor Emily Fisher, the company connects patients with licensed healthcare providers to obtain medical cannabis certifications and personalized clinical guidance. Leafwell also operates as a data and research company, leveraging real-world patient outcomes to publish peer-reviewed studies on cannabinoid efficacy. In 2026, the company expanded its offerings by launching an employer-sponsored medical cannabis benefit program, providing a compliance-safe, clinically guided alternative to high-cost pharmaceutical pathways for chronic pain, sleep disorders, and mental health conditions.